Secora Michael

CIK 00018559801 companySALT LAKE CITY, UT

SEC Profile

Transactions

Companies

Filings

CIK

0001855980

Recent Transactions

50 trades

Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-11-15$6.17/sh−11,937→ 1,487,694 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-11-13$7.66/sh−15,000→ 1,499,631 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-11-13$2.22/sh+39,375→ 1,514,631 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-11-13−39,375→ 337,635 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-11-12−39,375→ 377,010 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-11-12$2.22/sh+39,375→ 1,490,256 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-11-12$7.64/sh−15,000→ 1,475,256 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-10-09$2.22/sh+39,375→ 1,465,881 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-10-09−39,375→ 416,385 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-10-09$6.36/sh−15,000→ 1,450,881 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-10-08$6.32/sh−15,000→ 1,426,506 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-10-08$2.22/sh+39,375→ 1,441,506 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-10-08−39,375→ 455,760 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-09-11$6.32/sh−15,000→ 1,402,131 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-09-11−39,375→ 495,135 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-09-11$2.22/sh+39,375→ 1,417,131 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-09-10$6.17/sh−15,000→ 1,377,756 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-09-10$2.22/sh+39,375→ 1,392,756 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-09-10−39,375→ 534,510 total
Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-08-15$6.69/sh−11,962→ 1,353,381 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-08-14−39,375→ 573,885 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-08-14$6.35/sh−15,000→ 1,365,343 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-08-14$2.22/sh+39,375→ 1,380,343 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-08-13$6.35/sh−15,000→ 1,340,968 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-08-13−39,375→ 613,260 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-08-13$2.22/sh+39,375→ 1,355,968 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-07-10$2.22/sh+39,375→ 1,331,593 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-07-10$7.24/sh−15,000→ 1,316,593 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-07-10−39,375→ 652,635 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-07-09$2.22/sh+39,375→ 1,307,218 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-07-09$7.32/sh−15,000→ 1,292,218 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-07-09−39,375→ 692,010 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-06-14−39,375→ 731,385 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-06-14$9.27/sh−15,000→ 1,267,843 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-06-14$2.22/sh+39,375→ 1,282,843 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-06-13$2.22/sh+39,375→ 1,258,468 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-06-13$9.32/sh−15,000→ 1,243,468 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-06-13−39,375→ 770,760 total
Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-05-15$10.01/sh−11,962→ 1,219,093 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-04-17−37,500→ 810,135 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-04-17$2.22/sh+37,500→ 1,254,179 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-04-17$7.58/sh−23,124→ 1,231,055 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-04-16−37,500→ 847,635 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-04-16$2.22/sh+37,500→ 1,241,679 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-04-16$7.67/sh−25,000→ 1,216,679 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-03-13$2.22/sh+37,500→ 1,229,179 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-03-13$11.03/sh−25,000→ 1,204,179 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-03-13−37,500→ 885,135 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-03-12$2.22/sh+37,500→ 1,216,679 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-03-12$10.46/sh−25,000→ 1,191,679 total

Companies

RECURSION PHARMACEUTICALS, INC.
Chief Financial Officer
$RXRX

Recent Filings

Address

C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET

SALT LAKE CITY, UT, 84101

View on SEC.gov